MedPath

Clinical study on iron absorption after oral administration of ferric citrate hydrate - Riona-Oral Iron Absorption Trial (R-OIAT)

Not Applicable
Conditions
Hemodialysis patients
Registration Number
JPRN-UMIN000031406
Lead Sponsor
Kanazawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
4000
Inclusion Criteria

Not provided

Exclusion Criteria

1) infectious disease 2) malignancy 3) pregnancy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) serum Hepcidine-25 2) serum iron (first visit, 3month, 6month)
Secondary Outcome Measures
NameTimeMethod
1) UIBC 2) serum ferritin ( first visit, 3month, 6month)
© Copyright 2025. All Rights Reserved by MedPath